Gulec, S. A., Mesoloras, G., Dezarn, W. A., McNeillie, P., & Kennedy, A. S. (2007). Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio. BioMed Central.
Chicago Stili AlıntıGulec, Seza A., Geraldine Mesoloras, William A. Dezarn, Patrick McNeillie, ve Andrew S. Kennedy. Safety and Efficacy of Y-90 Microsphere Treatment in Patients With Primary and Metastatic Liver Cancer: The Tumor Selectivity of the Treatment As a Function of Tumor to Liver Flow Ratio. BioMed Central, 2007.
MLA AlıntıGulec, Seza A., et al. Safety and Efficacy of Y-90 Microsphere Treatment in Patients With Primary and Metastatic Liver Cancer: The Tumor Selectivity of the Treatment As a Function of Tumor to Liver Flow Ratio. BioMed Central, 2007.